Find a Tender for Medical Equipments, Pharmaceuticals And Personal Care Products

This project is a key project to be delivered as part of the North Wales Growth Deal (now Ambition North Wales).The Growth Deal is a partnership between the public sector and the private sector, supported by funding from UK Government and Welsh Government.The Growth Deal builds on the Growth Vision for North Wales, adopted in 2016: “a confident, cohesive region with sustainable economic growth, capitalising on the success of high value economic sectors and our connection to the economies of the Northern Powerhouse & Ireland.”The summary of the scope of the supply of goods contract will be as follows:The Supply and Delivery of an Ultrasound C-scan measurement EquipmentTraining for up to 5 personsMinimum 12 months Service maintenance and extended warrantySupply, Delivery and Installation BEFORE 31st May 2025 (if possible) or alternative date as agreed with the University.NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=146943.The buyer has indicated that it will accept electronic responses to this notice via the Postbox facility. A user guide is available at https://www.sell2wales.gov.wales/sitehelp/help_guides.aspx.Suppliers are advised to allow adequate time for uploading documents and to dispatch the electronic response well in advance of the closing time to avoid any last minute problems. The Overall Award Criteria for this procurement will be based on 30% Price and 70% Quality. Further details are set out in the ITT.(WA Ref:146943) [...]

Closed sterile needle guides for accurate breast biopsy sampling. 4 sizes to be supplied with needle gauge sizes and quantities indicated below. To be supplied on a yearly call off order. All to be compatible with Hologic mammography units , Achieve biopsy needles and ATEC Breast biopsy systems Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk [...]

The Framework Agreement will look to include the following range of products - Breast Implants including Sizers and Expanders, Nipple Implants, Calf and Gluteal Implants, Facial Implants, Chest Implants, Testicular Implants, Penile Implants. The precise quantities of the products that will be required by NHS Supply Chain under the terms of this Framework Agreement are unknown at the date of this notice. It is anticipated that initial expenditure will be in the region of £2,000,000 to £2,500,000.00: - Breast Implants including Nipple Implants, Sizers and Expanders in the region of £2,250,000; - Calf and Gluteal Implants in the region of £0 to £15,000 - Facial Implants in the region of £0 to £10,000 - Chest Implants in the region of £0 to £25,000 - Testicular Implants in the region of £0 to £75,000 - Penile Implants in the region of £0 to £125,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options) will be in the region of £8,000,000 to £10,000,000 excluding VAT. PLEASE NOTE: The proposed lotting structure maybe subject to change, however the scope of the product range for this framework will remain the same. The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies and/or services from suppliers not appointed to the Framework Agreement at its sole discretion. NHS [...]

The Framework Agreement will look to include the following range of products - Breast Implants including Sizers and Expanders, Nipple Implants, Calf and Gluteal Implants, Facial Implants, Chest Implants, Testicular Implants, Penile Implants. The precise quantities of the products that will be required by NHS Supply Chain under the terms of this Framework Agreement are unknown at the date of this notice. It is anticipated that initial expenditure will be in the region of £2,000,000 to £2,500,000.00: - Breast Implants including Nipple Implants, Sizers and Expanders in the region of £2,250,000; - Calf and Gluteal Implants in the region of £0 to £15,000 - Facial Implants in the region of £0 to £10,000 - Chest Implants in the region of £0 to £25,000 - Testicular Implants in the region of £0 to £75,000 - Penile Implants in the region of £0 to £125,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options) will be in the region of £8,000,000 to £10,000,000 excluding VAT. PLEASE NOTE: The proposed lotting structure maybe subject to change, however the scope of the product range for this framework will remain the same. The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies and/or services from suppliers not appointed to the Framework Agreement at its sole discretion. NHS [...]

This is a tender for drugs that are shortly to lose their patent exclusivity. [...]

NHS Greater Glasgow and Clyde (NHSGGC) are tendering for Aseptic Consumables. Aseptic preparation is an important part of the service delivered by pharmacy departments to facilitate accurate and timely administration of injectable medicines for patients. NHS Greater Glasgow and Clyde (NHSGGC) is the largest of the fourteen territorial NHS Boards in Scotland. All pharmacy aseptic dispensing is undertaken in three specialist units across GG&C hospital pharmacies. The following NHS pharmacy aseptic units are included, but this list is not exhaustive: Beatson West of Scotland Cancer Centre, New Victoria Hospital and The Royal Hospital for Children. Pharmacy aseptic units are responsible for the production of sterile medicines such as; chemotherapy, monoclonal antibody and other high risk injectable treatments. All products are prepared under strict aseptic (sterile) conditions. Stringent procedures are in place to ensure medicines are prepared to a consistently high standard to provide assurances of product quality and safety. Our GG&C aseptic services prepare approximately 97,000 products, supported by a dedicated workforce of 87 staff members. Each aseptic unit is led by a Chief Technician and operates under the oversight of a designated Responsible Pharmacist. The preparation of these medicines is carried out by skilled pharmacy technicians and assistants, ensuring adherence to strict regulatory requirements. Our pharmacy aseptic units ensure the safety and well-being of patients who require medications that are prepared under strict sterile conditions to prevent further complications. It is a complex and demanding activity requiring skilled staff, appropriate facilities and close monitoring and control. With the increasing complexity of modern medicines, procedures and strict regulations [...]

The purpose of this notice is to draw attention to a procurement NHS Supply Chain intends to commence during the subsequent 12 months. This framework is for the supply of Respiratory Solutions with products covering Oxygen Aerosol and Respiratory Therapy, Anaesthesia and Resuscitation, Diagnostics and N2O Destruction Solutions. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £25,000,000 to £27,750,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated total value is approximately £100,000,000.00 to £111,000,000.00 Excluding VAT (2+2 year term). The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies and/or services from suppliers not appointed to the Framework Agreement at its sole discretion. NHS Supply Chain intends to enter into arrangements under which it will be entitled to purchase supplies and/or services which it will make available for purchase by 1) any NHS Trust; 2) any other NHS entity; 3) any government department, agency or other statutory body and/or 4) any private sector entity active in the UK healthcare sector. Only NHS Supply Chain can order from the Framework Agreement and enter into contracts under it. [...]

The purpose of this notice is to draw attention to a procurement NHS Supply Chain intends to commence during the subsequent 12 months. This framework is for the supply of Respiratory Solutions with products covering Oxygen Aerosol and Respiratory Therapy, Anaesthesia and Resuscitation, Diagnostics and N2O Destruction Solutions. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £25,000,000 to £27,750,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated total value is approximately £100,000,000.00 to £111,000,000.00 Excluding VAT (2+2 year term). The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies and/or services from suppliers not appointed to the Framework Agreement at its sole discretion. NHS Supply Chain intends to enter into arrangements under which it will be entitled to purchase supplies and/or services which it will make available for purchase by 1) any NHS Trust; 2) any other NHS entity; 3) any government department, agency or other statutory body and/or 4) any private sector entity active in the UK healthcare sector. Only NHS Supply Chain can order from the Framework Agreement and enter into contracts under it. [...]

This Future Opportunity Notice (FON) with Request for Preliminary Information and expressions of interest is issued as part of an options appraisal process for Ashford and St Peter's Hospitals NHS Foundation Trust (the Trust). The Trust maternity team seeks Expressions of Interest in providing, and Preliminary Information about, an application for remote monitoring of the condition of patients who have gestational diabetes mellitus (GDM). The request is in the context that the contract for the present application for this purpose used by the Trust expires on 30 June 2025 so the Trust will require to procure a replacement and seeks information as to current applications available in the market regarding GDM monitoring. To respond to this opportunity, please go to: https://www.delta-esourcing.com/respond/9VC96TK4B6 If you experience any technical difficulties from accessing the above url, then please contact the Delta eSourcing Helpdesk on call 0800 923 9236 or email helpdesk@delta-esourcing.com. Please note that any questions on the request should be submitted via a message in the delta-esourcing platform and will not be reviewed in detail until 2 January 2025 at the earliest. Replies to the request are requested via the delta-sourcing platform by not later than 1200 Noon on Thursday 30 January 2025. Additional information: https://www.delta-esourcing.com/respond/9VC96TK4B6 Replies to the request are requested via the delta-sourcing platform by not later than 1200 Noon on Thursday 30 January 2025 To respond to this opportunity, please go to: https://www.delta-esourcing.com/respond/9VC96TK4B6 If you experience any technical difficulties from accessing the above url, then please contact the Delta eSourcing Helpdesk on call 0800 [...]

NHS Greater Glasgow and Clyde (NHSGGC) are tendering for Aseptic Consumables. Aseptic preparation is an important part of the service delivered by pharmacy departments to facilitate accurate and timely administration of injectable medicines for patients. NHS Greater Glasgow and Clyde (NHSGGC) is the largest of the fourteen territorial NHS Boards in Scotland. All pharmacy aseptic dispensing is undertaken in three specialist units across GG&C hospital pharmacies. The following NHS pharmacy aseptic units are included, but this list is not exhaustive: Beatson West of Scotland Cancer Centre, New Victoria Hospital and The Royal Hospital for Children. Pharmacy aseptic units are responsible for the production of sterile medicines such as; chemotherapy, monoclonal antibody and other high risk injectable treatments. All products are prepared under strict aseptic (sterile) conditions. Stringent procedures are in place to ensure medicines are prepared to a consistently high standard to provide assurances of product quality and safety. Our GG&C aseptic services prepare approximately 97,000 products, supported by a dedicated workforce of 87 staff members. Each aseptic unit is led by a Chief Technician and operates under the oversight of a designated Responsible Pharmacist. The preparation of these medicines is carried out by skilled pharmacy technicians and assistants, ensuring adherence to strict regulatory requirements. Our pharmacy aseptic units ensure the safety and well-being of patients who require medications that are prepared under strict sterile conditions to prevent further complications. It is a complex and demanding activity requiring skilled staff, appropriate facilities and close monitoring and control. With the increasing [...]